Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allergy & Asthma Consultants is a prominent network of specialized medical practices and clinical research centers focused on the diagnosis and treatment of allergic, respiratory, and immunologic disorders. While the name is used by several independent groups across the United States, the most notable entities, such as those in Atlanta and St. Louis, operate as major clinical trial sites for global pharmaceutical companies. These centers participate in Phase 1 through Phase 4 clinical trials for novel therapies, including monoclonal antibodies and small molecule inhibitors targeting conditions like chronic urticaria and severe asthma. In addition to providing standard-of-care treatments like immunotherapy and biologics, the organization contributes to the advancement of life sciences through its dedicated research divisions, such as Midwest Clinical Research. The group serves a broad patient population, offering specialized care for both pediatric and adult patients with complex immune-mediated conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allergy and Asthma Consultants.